Company: AILIM
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0001002910-25-000129
Chunk: 64

Company: Ameren Illinois Co
Filing Date: 2025-11-06
Form: 10-Q
Item: Part I, Item 1
Chunk 64
---
 and maturities of securities – nuclear decommissioning trust fund348 480 Other51 (1)Net cash used in investing activities(3,112)(3,106)Cash Flows From Financing Activities:Dividends on common stock(576)(535)Dividends paid to noncontrolling interest holders(4)(4)Short-term debt, net(239)1,002 Maturities and extinguishment of long-term debt(324)(849)Issuances of long-term debt1,960 1,610 Issuances of common stock35 30 Employee payroll taxes related to stock-based compensation(13)(8)Debt issuance costs(17)(19)Other— (15)Net cash provided by financing activities822 1,212 Net change in cash, cash equivalents, and restricted cash107 52 Cash, cash equivalents, and restricted cash at beginning of year328 272 Cash, cash equivalents, and restricted cash at end of period$435 $324 

The accompanying notes are an integral part of these consolidated financial statements.

6

AMEREN CORPORATION

CONSOLIDATED STATEMENT OF SHAREHOLDERS’ EQUITY

(Unaudited) (In millions, except per share amounts)

 Three Months Ended September 30,Nine Months Ended September 30, 2025202420252024Common Stock$3 $3 $3 $3 Other Paid-in Capital:Beginning of period7,541 7,246 7,513 7,216 Shares issued under the DRPlus and 401(k) plan10 9 35 30 Stock-based compensation activity8 9 11 18 Other paid-in capital, end of period7,559 7,264 7,559 7,264 Retained Earnings:Beginning of period4,784 4,299 4,604 4,136 Net income attributable to Ameren common shareholders640 456 1,204 975 Dividends on common stock(192)(179)(576)(535)Retained earnings, end of period5,232 4,576 5,232 4,576 Accumulated Other Comprehensive Loss:Derivative financial instruments, beginning of period(3)— 3 — Change in derivative financial instruments— — (6)— Derivative financial instruments, end of period(3)— (3)— Deferred retirement benefit